CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Revenue
Operating expenses
Research and development	3,204,895	4,133,925
General and administrative	2,204,521	5,543,173
Total operating expenses	5,409,416	9,677,098
Loss from operations	(5,409,416)	(9,677,098)
Other income (expense)
Interest income	6,417	128,762
Other income	931,276
Total other income (expense)	937,693	128,762
Net loss	$ (4,471,723)	$ (9,548,336)
Basic and Diluted Loss per Common Share	$ (0.05)	$ (0.11)
Weighted average number of common shares outstanding - basic and diluted	87,352,364	87,352,364